Displaying drugs 15026 - 15050 of 15128 in total
Benzo[B]Thiophene-2-Carboxamidine
Experimental
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
Flaviolin
Experimental
Quinalizarin
Experimental
Ganglioside GM1
Investigational
Matched Iupac: … hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid …
CRA_1801
Experimental
Bis(5-Amidino-2-Benzimidazolyl)Methanone
Experimental
4-Iodobenzo[B]Thiophene-2-Carboxamidine
Experimental
ZK-806711
Experimental
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone
Experimental
XL019
XL019 is a selective inhibitor of the cytoplasmic tyrosine kinase JAK2. An IND for XL019 was filed by Exelixis in May 2007.
Investigational
5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone
Experimental
Metizoline
Experimental
Gantacurium
Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.
Investigational
Displaying drugs 15026 - 15050 of 15128 in total